The White House’s Operation Warp Speed chief, Dr. Moncef Slaaoui, who is leading the Trump administration’s efforts to expedite vaccine development for the novel Wuhan coronavirus, said Friday that 20 million doses would be distributed in December.
On Monday, pharmaceutical giant Pfizer announced its leading candidate for a COVID vaccine proved 90 percent effective in late-stage large-scale clinical trials getting ready for public distribution.
BREAKING: Two vaccines that are currently completing Phase 3 trials could be approved by the US FDA in a matter of weeks – ready to immunise 20 million Americans in December and 25-30 million a month subsequently. pic.twitter.com/hqCf6YYgB6
— Tom Harwood (@tomhfh) November 13, 2020
Slaaoui said the U.S. could be on the verge of benefiting from two vaccines currently in the process of completing phase three trials, along with two therapeutics on their way to being granted emergency-use authorization by the Food and Drug Administration (FDA) by year’s end.
“I think it’s